Sharps Compliance Corp. (SMED) Stock Analysis
DELISTED 2022
What happened to Sharps Compliance Corp. (SMED) stock?
Sharps Compliance Corp. (SMED) no longer trades on public markets. It was delisted in August 2022. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Sharps Compliance Corp. (SMED) trades at $8.75. Sharps Compliance Corp. specializes in medical, pharmaceutical, and hazardous waste management services in the U. S. Sector: Industrials.
Last analyzed: May 8, 2026Analyst Coverage for SMED: SMED does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SMED against Industrials peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
SMED: 1/2 scored disciplines lean bullish. Dominant signal: Moon AI bullish.
How is this calculated? →Sharps Compliance Corp. (SMED) Industrial Operations Profile
Sharps Compliance Corp. is a leader in medical and hazardous waste management, providing comprehensive waste disposal solutions that ensure safety and compliance for healthcare providers across the United States.
What Is the Investment Thesis for SMED?
Sharps Compliance Corp. is positioned for growth driven by increasing regulatory scrutiny and the rising demand for safe waste disposal solutions in the healthcare sector. The company has a P/E ratio of 11.6, indicating potential for attractive valuations compared to industry peers. Key value drivers include its diverse product offerings and established relationships with healthcare providers, which enhance customer retention. The ongoing trend towards at-home healthcare services is expected to bolster demand for Sharps’ TakeAway Recovery System, while the company's profit margin of 16.8% reflects operational efficiency. As healthcare facilities expand, Sharps is likely to benefit from increased waste generation, providing a solid foundation for revenue growth in the coming years.
Based on FMP financials and quantitative analysis
SMED Key Highlights
P/E ratio of 11.6 indicates potential for attractive valuations compared to industry peers.
- Profit margin of 16.8% demonstrates strong operational efficiency.
- Gross margin of 37.8% exceeds industry averages, reflecting effective cost management.
- Beta of 1.28 suggests higher volatility compared to the market, indicating potential for significant price movements.
- No dividend yield, focusing reinvestment into growth initiatives.
Who Are SMED's Competitors?
SMED is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| RSG Republic Services, Inc. | $219.50 | -0.70% | $67.5B | 66 |
| WM Waste Management, Inc. | $224.92 | -0.07% | $89.9B | 66 |
| SRCL Stericycle, Inc. | $61.98 | +0.83% | $5.75B | — |
| VEOEF Veolia Environnement S.A. | $40.43 | +2.52% | $29.6B | 45 |
| CLH Clean Harbors, Inc. | $321.95 | -1.01% | $17.0B | 66 |
| CWST Casella Waste Systems, Inc. | $93.05 | +0.22% | $5.83B | 51 |
| CHFFF China Everbright Environment Group Limited | $0.67 | +0.00% | $4.12B | 47 |
| CHFFY China Everbright Environment Group Limited | $6.70 | +0.22% | $4.12B | 46 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SMED's Key Strengths?
Strong profit margin of 16.8% indicating operational efficiency.
- Established brand recognition in the medical waste management sector.
- Diverse product offerings catering to various healthcare needs.
What Are SMED's Weaknesses?
Lack of dividend payments may deter income-focused investors.
- Dependence on the U.S. healthcare market for revenue.
- Limited international presence compared to some competitors.
What Could Drive SMED Stock Higher?
Expansion of home healthcare services expected to drive demand for Sharps' products.
- Increasing regulatory scrutiny on medical waste disposal enhancing market opportunities.
- Continuous innovation in product offerings to meet evolving customer needs.
What Are the Key Risks for SMED?
Economic downturns may reduce healthcare spending and waste generation.
- Intense competition could pressure pricing and market share.
- Regulatory changes may increase operational costs or compliance burdens.
What Are the Growth Opportunities for SMED?
- Expansion of Home Healthcare Services: The growing trend towards home healthcare is expected to drive demand for Sharps' TakeAway Recovery System. As more patients receive care at home, the need for safe disposal of medical waste will increase. The home healthcare market is projected to grow at a CAGR of 7.9% from 2021 to 2028, providing a significant opportunity for Sharps to expand its customer base and service offerings.
- Increased Regulatory Compliance: Stricter regulations surrounding medical waste disposal are creating a favorable environment for Sharps Compliance. As healthcare facilities seek to comply with these regulations, the demand for Sharps’ comprehensive waste management solutions is likely to rise. The company's established reputation in compliance and safety positions it well to capture this growing market segment.
- Innovative Product Development: Sharps is continuously innovating its product offerings to meet evolving customer needs. The introduction of new solutions, such as the Hazardous Drug Spill Control Kit, enhances its service portfolio. By investing in research and development, Sharps can maintain its competitive edge and attract new clients, potentially increasing revenue streams.
- Partnerships with Pharmaceutical Manufacturers: Collaborating with pharmaceutical companies to provide waste management solutions for expired or unused medications can open new revenue channels for Sharps. Given the increasing focus on proper medication disposal, these partnerships can enhance Sharps' market presence and drive growth.
- Geographic Expansion: Sharps Compliance has the potential to expand its services into underserved regions. By targeting areas with limited access to safe waste disposal options, the company can capture new markets and increase its overall footprint, contributing to long-term growth.
What Are SMED's Competitive Advantages?
- Established reputation for compliance and safety in waste management.
- Diverse range of specialized products tailored to the healthcare sector.
- Strong relationships with healthcare providers enhance customer loyalty.
- Innovative solutions that address evolving regulatory requirements.
What Does SMED Do?
Sharps Compliance Corp. was founded in 1992 and is headquartered in Houston, Texas. The company has established itself as a vital player in the waste management sector, particularly focusing on medical, pharmaceutical, and hazardous waste. Its innovative offerings include the Sharps Recovery System, which is designed for the containment, transportation, treatment, and tracking of medical waste generated outside of hospitals and healthcare facilities. The TakeAway Recovery System is another key product, facilitating the safe disposal of used needles and syringes. Additionally, Sharps provides Route-Based Pickup Services for medical and hazardous waste, and MedSafe, a solution for the collection and disposal of unwanted medications. The company also addresses various waste management needs with specialized programs such as the Inhaler Disposal and Hazardous Drug Spill Control Kit. Sharps Compliance serves a diverse customer base, including home healthcare providers, retail clinics, pharmaceutical manufacturers, and government agencies, demonstrating its broad market reach. Over the years, the company has evolved its service offerings to meet increasing regulatory demands and the growing need for safe waste disposal solutions in the healthcare sector, positioning itself as a trusted partner in compliance and safety for its clients.
What Products and Services Does SMED Offer?
- Provide medical waste management services for healthcare facilities.
- Offer the Sharps Recovery System for safe containment and tracking of medical waste.
- Facilitate the disposal of used needles and syringes through the TakeAway Recovery System.
- Deliver Route-Based Pickup Services for efficient waste collection.
- Implement the MedSafe solution for safe disposal of unwanted medications.
- Develop specialized programs for hazardous waste and compliance training.
How Does SMED Make Money?
- Generate revenue through the sale of waste management solutions and services.
- Charge fees for waste pickup and disposal services provided to healthcare clients.
- Offer subscription-based services for ongoing compliance and training programs.
- Leverage partnerships with healthcare providers and pharmaceutical companies to enhance service offerings.
What Industry Does SMED Operate In?
The waste management industry is experiencing robust growth, driven by increasing healthcare regulations and a heightened focus on environmental sustainability. The global medical waste management market is projected to reach approximately $38 billion by 2027, growing at a CAGR of around 5.5%. As a key player in this space, Sharps Compliance Corp. is well-positioned to capitalize on these trends, particularly with its innovative solutions tailored for the healthcare sector. The competitive landscape includes both large and small firms, but Sharps differentiates itself through specialized services and a strong compliance framework, catering specifically to the unique needs of healthcare providers.
Who Are SMED's Key Customers?
- Home healthcare providers seeking safe waste disposal solutions.
- Retail clinics and immunizing pharmacies requiring efficient waste management.
- Pharmaceutical manufacturers needing compliant disposal of expired medications.
- Professional offices and assisted living facilities managing medical waste.
- Government agencies focused on public health and safety.
Key Financial Metrics
Return on equity for Sharps Compliance Corp. stands at 33.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 17.1%, showing how much profit it generates from its asset base. SMED trades at a trailing price-to-earnings ratio of 11.58, below the Industrials sector average of ~32x. A current ratio of 2.63 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 8.6%, the inverse of the P/E and a quick read on earnings relative to price.
Company Profile
Sharps Compliance Corp. operates in the Waste Management industry within the Industrials sector. It is headquartered in Houston, US. The company is led by CEO David Tusa. SMED has traded publicly since 1994.
SMED Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Strong profit margin of 16.8% indicating operational efficiency.
- Established brand recognition in the medical waste management sector.
- Diverse product offerings catering to various healthcare needs.
- Upcoming: Expansion of home healthcare services expected to drive demand for Sharps' products.
Bear Case
- Lack of dividend payments may deter income-focused investors.
- Dependence on the U.S. healthcare market for revenue.
- Limited international presence compared to some competitors.
- Potential: Economic downturns may reduce healthcare spending and waste generation.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
SMED Latest News
No recent news available for SMED.
Classification
Industry Waste ManagementLeadership: David Tusa
CEO
David Tusa has extensive experience in the waste management and healthcare sectors. He has held various leadership roles, focusing on operational efficiency and strategic growth. Tusa holds a degree in Business Administration and has a proven track record of driving company performance and innovation.
Track Record: Under David Tusa's leadership, Sharps Compliance has expanded its service offerings and improved operational efficiencies, contributing to sustained profitability and market presence.
Sharps Compliance Corp. Industrials Stock: Key Questions Answered
What happened to Sharps Compliance Corp. (SMED) stock?
Sharps Compliance Corp. (SMED) no longer trades on public markets. It was delisted in August 2022. The figures below are historical and are not a current quote.
Can I still buy SMED shares?
No. SMED stopped trading on public markets in August 2022, so the shares are not available through a broker. Anything you see quoted for SMED elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before SMED stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Sharps Compliance Corp.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does Sharps Compliance Corp. do?
Sharps Compliance Corp. specializes in medical, pharmaceutical, and hazardous waste management services. The company offers a variety of solutions, including the Sharps Recovery System and TakeAway Recovery System, designed to ensure the safe disposal of medical waste generated outside healthcare facilities. With a focus on compliance and safety, Sharps serves a diverse range of customers, including home healthcare providers, retail clinics, and government agencies.
What do analysts say about SMED stock?
Analysts generally view Sharps Compliance Corp. favorably, noting its strong profit margins and solid growth potential driven by increasing regulatory requirements in the waste management sector. The company's P/E ratio of 11.6 is considered attractive compared to industry peers, and its diverse product offerings position it well for future growth. However, analysts also highlight the importance of monitoring competitive pressures and regulatory changes that could impact performance.
What are the main risks for SMED?
Sharps Compliance Corp. faces several risks, including potential economic downturns that could reduce healthcare spending, impacting waste generation and disposal needs. Additionally, the company operates in a highly competitive environment, where larger firms may exert pricing pressure. Ongoing regulatory changes could also introduce new compliance costs or operational challenges, necessitating vigilance in adapting to the evolving landscape.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Data is based on the latest available financial and company information.